Treatment of Alcohol Use Disorder

Pharmacologic Interventions

• The American Association for the Study of Liver Diseases recommends that FDA-approved medications should be used in combination with counseling for patients without advanced alcoholic liver disease (ALD) 1, 2
• The American College of Gastroenterology suggests that naltrexone (50mg daily) reduces relapse to heavy drinking and drinking frequency, although the exact mechanism is not specified in the provided text, it is implied to be effective 1, 2
• Acamprosate helps maintain abstinence, particularly in recently abstinent patients, as recommended by the American Association for the Study of Liver Diseases 1, 2
• Disulfiram should only be used in supervised settings with highly motivated patients, according to the American Medical Association 1, 2
• Baclofen is safe and effective to prevent alcohol relapse in patients with advanced alcoholic liver disease, as stated by the European Association for the Study of the Liver 1, 2
• Naltrexone and acamprosate should be avoided in patients with advanced ALD due to potential side effects, as warned by the American Association for the Study of Liver Diseases 1

Psychosocial Interventions

• Brief motivational interventions should be routinely implemented, as they have proven efficacy in reducing alcohol consumption and related morbidity and mortality, according to the World Health Organization 1, 2
• The FRAMES model (Feedback, Responsibility, Advice, Menu, Empathy, Self-efficacy) is an effective structured approach for brief interventions, as recommended by the National Institute on Alcohol Abuse and Alcoholism 3
• Patients should be actively encouraged to engage with mutual help groups such as Alcoholics Anonymous, as suggested by the American Society of Addiction Medicine 3, 4

Implementation Algorithm

• The AUDIT (Alcohol Use Disorders Identification Test) should be used as the gold standard screening tool, as recommended by the World Health Organization 1
• Benzodiazepines are the treatment of choice for patients with acute withdrawal syndrome, according to the American College of Emergency Physicians 1, 2
• Oral thiamine should be provided to all patients, and parenteral thiamine for high-risk patients, as recommended by the National Institute on Alcohol Abuse and Alcoholism 5
• Brief motivational interventions using the FRAMES model or five A's approach (Ask, Advise, Assess, Assist, Arrange) should be implemented, as suggested by the American Academy of Family Physicians 1, 3
• Family members should be involved in treatment when appropriate, as recommended by the American Academy of Pediatrics 3, 5

Psychotherapy Approaches for Alcohol Use Disorder Based on Motivational Stages

Understanding Motivational Stages and Appropriate Interventions

• Brief motivational interventions should be routinely implemented as the first-line psychotherapy approach for individuals with alcohol use disorder across different stages of motivation, as they have proven efficacy in reducing alcohol consumption and related morbidity and mortality, according to the Journal of Hepatology 6
• For patients who are ambivalent about alcohol cessation, motivational interviewing has been shown to help patients change behaviors, including alcohol use, as reported in Hepatology 7
• The FRAMES model is particularly effective for patients in early stages of change, providing structured feedback about drinking dangers while emphasizing patient autonomy, as noted in Clinical and Molecular Hepatology 8, 9
• Brief interventions using motivational interviewing techniques can be implemented in various healthcare settings and are cost-effective for patients with mild alcohol-related liver disease, according to Clinical and Molecular Hepatology 10
• Cognitive-behavioral therapy (CBT) becomes more appropriate as patients recognize their alcohol problem and prepare for change, as stated in Hepatology 7
• Motivational enhancement therapy (MET) builds on motivational interviewing principles to strengthen commitment to change during the contemplation/preparation stage, as reported in Hepatology 7
• Behavioral therapy involving relaxation techniques and assertive training helps patients use methods other than alcohol to alleviate anxiety, as noted in Clinical and Molecular Hepatology 10

Special Considerations for Different Populations

• For patients with advanced alcoholic liver disease, psychosocial interventions should be combined with appropriate pharmacotherapy, such as baclofen, which has demonstrated safety and efficacy in this population, according to the Journal of Hepatology and Clinical and Molecular Hepatology 6, 10

Maintenance Stage

• Social skills training and coping skills training help maintain long-term abstinence by providing practical strategies to avoid relapse, as reported in Clinical and Molecular Hepatology 8
• Family/couples counseling and network therapy should be incorporated to strengthen support systems during maintenance, as stated in Hepatology 7

Evidence-Based Treatment for Alcohol Use Disorder

First-Line Treatment: Brief Behavioral Counseling

• The U.S. Preventive Services Task Force found that brief counseling interventions in adults with risky or hazardous drinking reduce heavy drinking episodes, with a 12% absolute increase in the proportion reporting no heavy drinking episodes after 1 year, and reduce total weekly alcohol consumption by approximately 3.6 drinks per week at 12-month follow-up 11, 12, 13
• Brief multicontact behavioral counseling interventions outperform single-session interventions, demonstrating the need for ongoing engagement 11, 12, 13

Pharmacotherapy

• The American Association for the Study of Liver Diseases recommends FDA-approved medications be used in combination with counseling, although only 1.6% of Americans with alcohol use disorder receive medications despite strong evidence for their efficacy 14
• Naltrexone reduces the likelihood of return to any drinking by 5% and binge-drinking risk by 10%, and reduces relapse to heavy drinking 11, 12, 13

Mutual Help Groups

• The American Society of Addiction Medicine recommends that healthcare providers familiarize themselves with locally available mutual help groups and encourage patient engagement, as this peer-support model has more evidence than psychodynamic therapy for alcohol use disorder 14

Clinical Guidelines

• No major clinical guidelines (USPSTF, WHO, American Association for the Study of Liver Diseases, Korean Association for the Study of the Liver) mention psychodynamic psychotherapy as a treatment option for alcohol use disorder 11, 12, 13, 14, 15, 16
• The evidence base focuses exclusively on brief interventions, CBT, motivational approaches, and pharmacotherapy, all of which target drinking behavior directly rather than exploring unconscious motivations 11, 12, 14